These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 16298482

  • 21. Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease.
    Marongiu R, Ghezzi D, Ialongo T, Soleti F, Elia A, Cavone S, Albanese A, Altavista MC, Barone P, Brusa L, Cortelli P, Petrozzi L, Scaglione C, Stanzione P, Tinazzi M, Zeviani M, Dallapiccola B, Bentivoglio AR, Valente EM, Garavaglia B, Italian PD Study Group.
    Mov Disord; 2006 Aug; 21(8):1232-5. PubMed ID: 16622859
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical features of LRRK2-associated Parkinson's disease in central Norway.
    Aasly JO, Toft M, Fernandez-Mata I, Kachergus J, Hulihan M, White LR, Farrer M.
    Ann Neurol; 2005 May; 57(5):762-5. PubMed ID: 15852371
    [Abstract] [Full Text] [Related]

  • 24. The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.
    Kalinderi K, Fidani L, Bostantjopoulou S, Katsarou Z, Kotsis A.
    Eur J Neurol; 2007 Oct; 14(10):1088-90. PubMed ID: 17880562
    [Abstract] [Full Text] [Related]

  • 25. Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease.
    Yescas P, López M, Monroy N, Boll MC, Rodríguez-Violante M, Rodríguez U, Ochoa A, Alonso ME.
    Neurosci Lett; 2010 Nov 19; 485(2):79-82. PubMed ID: 20727385
    [Abstract] [Full Text] [Related]

  • 26. Genetic analysis of LRRK2 mutations in patients with Parkinson disease.
    Deng H, Le W, Guo Y, Hunter CB, Xie W, Huang M, Jankovic J.
    J Neurol Sci; 2006 Dec 21; 251(1-2):102-6. PubMed ID: 17097110
    [Abstract] [Full Text] [Related]

  • 27. LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity.
    Gorostidi A, Ruiz-Martínez J, Lopez de Munain A, Alzualde A, Martí Massó JF.
    Neurogenetics; 2009 Apr 21; 10(2):157-9. PubMed ID: 19020907
    [Abstract] [Full Text] [Related]

  • 28. Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain).
    Ruiz-Martínez J, Gorostidi A, Ibañez B, Alzualde A, Otaegui D, Moreno F, López de Munain A, Bergareche A, Gómez-Esteban JC, Martí Massó JF.
    Mov Disord; 2010 Oct 30; 25(14):2340-5. PubMed ID: 20721916
    [Abstract] [Full Text] [Related]

  • 29. Absence/rarity of commonly reported LRRK2 mutations in Indian Parkinson's disease patients.
    Punia S, Behari M, Govindappa ST, Swaminath PV, Jayaram S, Goyal V, Muthane UB, Juyal RC, Thelma BK.
    Neurosci Lett; 2006 Dec 01; 409(2):83-8. PubMed ID: 17052850
    [Abstract] [Full Text] [Related]

  • 30. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
    Bandrés-Ciga S, Mencacci NE, Durán R, Barrero FJ, Escamilla-Sevilla F, Morgan S, Hehir J, Vives F, Hardy J, Pittman AM.
    Neurobiol Aging; 2016 Jan 01; 37():210.e1-210.e5. PubMed ID: 26518746
    [Abstract] [Full Text] [Related]

  • 31. Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.
    Hatano T, Funayama M, Kubo SI, Mata IF, Oji Y, Mori A, Zabetian CP, Waldherr SM, Yoshino H, Oyama G, Shimo Y, Fujimoto KI, Oshima H, Kunii Y, Yabe H, Mizuno Y, Hattori N.
    Neurobiol Aging; 2014 Nov 01; 35(11):2656.e17-2656.e23. PubMed ID: 24973808
    [Abstract] [Full Text] [Related]

  • 32. Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries.
    Tomiyama H, Li Y, Funayama M, Hasegawa K, Yoshino H, Kubo S, Sato K, Hattori T, Lu CS, Inzelberg R, Djaldetti R, Melamed E, Amouri R, Gouider-Khouja N, Hentati F, Hatano Y, Wang M, Imamichi Y, Mizoguchi K, Miyajima H, Obata F, Toda T, Farrer MJ, Mizuno Y, Hattori N.
    Mov Disord; 2006 Aug 01; 21(8):1102-8. PubMed ID: 16622854
    [Abstract] [Full Text] [Related]

  • 33. Genetic screening for two LRRK2 mutations in French patients with idiopathic Parkinson's disease.
    Funalot B, Nichols WC, Pérez-Tur J, Mercier G, Lucotte G.
    Genet Test; 2006 Aug 01; 10(4):290-3. PubMed ID: 17253937
    [Abstract] [Full Text] [Related]

  • 34. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
    Lesage S, Janin S, Lohmann E, Leutenegger AL, Leclere L, Viallet F, Pollak P, Durif F, Thobois S, Layet V, Vidailhet M, Agid Y, Dürr A, Brice A, French Parkinson's Disease Genetics Study Group, Bonnet AM, Borg M, Broussolle E, Damier P, Destée A, Martinez M, Penet C, Rasco O, Tison F, Tranchan C, Vérin M.
    Arch Neurol; 2007 Mar 01; 64(3):425-30. PubMed ID: 17353388
    [Abstract] [Full Text] [Related]

  • 35. Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients.
    Duque AF, Lopez JC, Benitez B, Hernandez H, Yunis JJ, Fernandez W, Arboleda H, Arboleda G.
    Colomb Med (Cali); 2015 Sep 30; 46(3):117-21. PubMed ID: 26600626
    [Abstract] [Full Text] [Related]

  • 36. Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics.
    Kay DM, Zabetian CP, Factor SA, Nutt JG, Samii A, Griffith A, Bird TD, Kramer P, Higgins DS, Payami H.
    Mov Disord; 2006 Apr 30; 21(4):519-23. PubMed ID: 16250030
    [Abstract] [Full Text] [Related]

  • 37. The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor.
    Deng H, Le W, Davidson AL, Xie W, Jankovic J.
    Neurosci Lett; 2006 Oct 23; 407(2):97-100. PubMed ID: 16939701
    [Abstract] [Full Text] [Related]

  • 38. The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers.
    Inzelberg R, Cohen OS, Aharon-Peretz J, Schlesinger I, Gershoni-Baruch R, Djaldetti R, Nitsan Z, Ephraty L, Tunkel O, Kozlova E, Inzelberg L, Kaplan N, Fixler Mehr T, Mory A, Dagan E, Schechtman E, Friedman E, Hassin-Baer S.
    Neurology; 2012 Mar 13; 78(11):781-6. PubMed ID: 22323743
    [Abstract] [Full Text] [Related]

  • 39. Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.
    Nabli F, Ben Sassi S, Amouri R, Duda JE, Farrer MJ, Hentati F.
    Mov Disord; 2015 Feb 13; 30(2):253-8. PubMed ID: 25487881
    [Abstract] [Full Text] [Related]

  • 40. The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.
    Goldwurm S, Di Fonzo A, Simons EJ, Rohé CF, Zini M, Canesi M, Tesei S, Zecchinelli A, Antonini A, Mariani C, Meucci N, Sacilotto G, Sironi F, Salani G, Ferreira J, Chien HF, Fabrizio E, Vanacore N, Dalla Libera A, Stocchi F, Diroma C, Lamberti P, Sampaio C, Meco G, Barbosa E, Bertoli-Avella AM, Breedveld GJ, Oostra BA, Pezzoli G, Bonifati V.
    J Med Genet; 2005 Nov 13; 42(11):e65. PubMed ID: 16272257
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.